Like Imitrex, it is made to be taken at the onset of a migraine, but is supposed to work faster and better to reduce migraine pain.
GSK has spent several years and millions of dollars researching and "pre-marketing" Treximet in anticipation of FDA approval and product launch.
So what's the deal? Is this really better than Imitrex alone? From a strict treatment point of view, yes, the medication probably is better than Imitrex alone for a migraine. The reason for this is twofold.